FDA Approved: PROMACTA — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved PROMACTA (eltrombopag olamine) in its original application for the treatment of immune thrombocytopenia. This represents the initial approval of el…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Promacta (eltrombopag)

Snippet

ORIG AP for PROMACTA (ELTROMBOPAG OLAMINE)